KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.61 $7.24 Friday, 26th Apr 2024 AFMD stock ended at $5.03. This is 3.07% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.35% from a day low at $4.88 to a day high of $5.19.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Mar 07, 2016 $44.30 $44.30 $44.30 $44.30 28 700
Mar 04, 2016 $42.40 $42.40 $42.40 $42.40 31 660
Mar 03, 2016 $39.40 $39.40 $39.40 $39.40 37 290
Mar 02, 2016 $38.60 $38.60 $38.60 $38.60 22 330
Mar 01, 2016 $36.80 $36.80 $36.80 $36.80 37 520
Feb 29, 2016 $31.90 $31.90 $31.90 $31.90 7 330
Feb 26, 2016 $32.80 $32.80 $32.80 $32.80 11 930
Feb 25, 2016 $31.50 $31.50 $31.50 $31.50 7 110
Feb 24, 2016 $32.50 $32.50 $32.50 $32.50 8 990
Feb 23, 2016 $30.20 $30.20 $30.20 $30.20 107 700
Feb 22, 2016 $32.30 $32.30 $32.30 $32.30 14 570
Feb 19, 2016 $33.20 $33.20 $33.20 $33.20 9 170
Feb 18, 2016 $32.40 $32.40 $32.40 $32.40 14 820
Feb 17, 2016 $34.00 $34.00 $34.00 $34.00 11 880
Feb 16, 2016 $32.20 $32.20 $32.20 $32.20 7 670
Feb 12, 2016 $31.60 $31.60 $31.60 $31.60 19 010
Feb 11, 2016 $28.70 $28.70 $28.70 $28.70 25 510
Feb 10, 2016 $29.10 $29.10 $29.10 $29.10 21 240
Feb 09, 2016 $30.70 $30.70 $30.70 $30.70 29 420
Feb 08, 2016 $29.90 $29.90 $29.90 $29.90 28 170
Feb 05, 2016 $32.00 $32.00 $32.00 $32.00 25 250
Feb 04, 2016 $33.20 $33.20 $33.20 $33.20 14 260
Feb 03, 2016 $33.00 $33.00 $33.00 $33.00 20 690
Feb 02, 2016 $33.00 $33.00 $33.00 $33.00 19 040
Feb 01, 2016 $34.50 $34.50 $34.50 $34.50 16 160
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT